SLC19A3 and malignant colon neoplasm: Mika et al. demonstrated in colon cancer cell lines that altering the expression of thiamine transporter 2 (THTR2) (SLC19A3) can modulate DNA methylation and histone deacetylation, associated with thiamine deficiency in advanced colon cancer.